Patheon to participate in industry panels at Interphex

Patheon will showcase Patheon OneSource, the industry-leading solution that provides a simplified and customised offering, including both drug substance and drug production services to help clients get to market faster and cost effectively

Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, will showcase its broad set of development and manufacturing services, and the company’s integrated offering at Interphex in New York City from 21 to 23 April 2015.

Company leaders will offer industry insights during key panel discussions.

Franco Negron, senior vice president of drug product services in North America for Patheon, will participate in the Executive Perspectives panel, moderated by Jim Miller, founder and president of PharmSource Information Services, on Wednesday 22 April at 1.15pm, to discuss industry trends and consolidation, relationships and strategic partnerships with large and small pharma companies, as well as the future of the industry.

Andrew McNicoll, vice president of quality systems and compliance for Patheon, will participate in a panel focused on Quality Agreements on Wednesday 22 April at 2.15pm. The panel will cover approaches and best practices, and highlight differences in how quality agreements are employed to ensure regulatory compliance when working with clients.

While at Interphex, Patheon will showcase Patheon OneSource, the industry-leading solution that provides a simplified and customised offering, including both drug substance and drug production services to help clients get to market faster and cost effectively.

Executives, technical and scientific experts from Patheon will be available to discuss the company’s full suite of services and capabilities at booth 1424. To schedule a meeting in advance, please visit www.patheon.com/Knowledge-Library/Events.

Companies